KOSDAQ - Delayed Quote KRW

ImmuneOncia (424870.KQ)

6,380.00
-130.00
(-2.00%)
At close: June 2 at 3:30:09 PM GMT+9
Currency in KRW All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
--
654,539.17
--
--
--
Operating Expense
13,229,707
--
--
--
11,932,283
Diluted EPS
--
--
--
-203.00
--
Total Operating Income as Reported
--
--
--
--
-11,896,335.59
Total Expenses
--
--
--
--
11,932,283
Net Income from Continuing & Discontinued Operation
-5,687,000.02
--
8,864,020.83
-3,491,759.02
--
Interest Expense
6,925
--
--
--
--
Net Income from Continuing Operation Net Minority Interest
--
--
8,864,020.83
--
--
Tax Effect of Unusual Items
--
0
--
--
--
12/31/2021 - 5/19/2025

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CHRO Channel Therapeutics Corporation
1.0200
+10.22%
 
ATXI Avenue Therapeutics, Inc.
0.2595
-0.19%
 
AARD Aardvark Therapeutics, Inc.
11.13
+6.61%
 
VINC Vincerx Pharma, Inc.
0.0550
+13.40%
 
CELU Celularity Inc.
2.2400
+6.16%
 
CGON CG Oncology, Inc.
26.59
+3.79%
 
BLTE Belite Bio, Inc
65.02
+0.23%
 
STRO Sutro Biopharma, Inc.
0.9048
+0.79%
 
SLNO Soleno Therapeutics, Inc.
75.66
+3.15%
 
SRNE Sorrento Therapeutics, Inc.
0.0013
0.00%